Model of unidirectional transluminal gene transfer

Molecular Therapy

Volumn 9, Issue 2, 2004, Pages 305-310

  Arap, Marco A ^a   Lahdenranta, Johanna ^a   Hajitou, Amin ^a   Marini III, Frank C ^a   Wood, Christopher G ^a   Wright, Kenneth C ^a   Fueyo, Juan ^a   Arap, Wadih ^a   Pasqualini, Renata ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

AAV; Adenovirus; Ex vivo model; Gene transfer; Green fluorescent protein; Transduction; galactosidase

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; EX VIVO STUDY; EXPERIMENTAL MODEL; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PERITONEUM; REPORTER GENE; SAMPLE SIZE; UROTHELIUM; VISCERA;

ADENOVIRIDAE;

EID: 1342290207     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2003.11.016     Document Type: Article

References (26)

1. Yoo, J. J., Soker, S., Lin, L. F., Mehegan, K., Guthrie, P. D., and Atala, A. (1999). Direct in vivo gene transfer to urological organs. J. Urol. 162: 1115-1118.
2. Siemens, D. R., Austin, J. C., See, W. A., Tartaglia, J., and Ratliff, T. L. (2001). Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium. J. Urol. 165: 667-671.
3. Oh, S., Lee, M., Ko, K. S., Choi, S., and Kim, S. W. (2003). GLP-1 gene delivery for the treatment of type 2 diabetes. Mol. Ther. 7: 478-483.
4. Lin, L. F., Zhu, G., Yoo, J. J., Soker, S., Sukhatme, V. P., and Atala, A. (2002). A system for the enhancement of adenovirus mediated gene transfer to uro-epithelium. J. Urol. 168: 813-818.
5. Lattime, E. C., and Gerson, S. L. (2002). Gene Therapy of Cancer, 2nd ed. Academic Press, San Diego.
6. Furuhata, S., Ide, H., Miura, Y., Yoshida, T., and Aoki, K. (2003). Development of a prostate-specific promoter for gene therapy against androgen-independent prostate cancer. Mol. Ther. 7: 366-374.
7. Fewell, J. G., et al. (2001). Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol. Ther. 3: 574-583.
8. Byrnes, A. P., Wood, M. J., and Charlton, H. M. (1996). Role of T cells in inflammation caused by adenovirus vectors in the brain. Gene Ther. 3: 644-651.
9. Goodman, J. C., et al. (1996). Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies. Hum. Gene Ther. 7: 1241-1250.
10. Chester, J. D., Kennedy, W., Hall, G. D., Selby, P. J., and Knowles, M. A. (2003). Adenovirus-mediated gene therapy for bladder cancer: efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivo. Gene Ther. 10: 172-179.
11. Ardelt, P. U., et al. (2003). Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands. J. Urol. 169: 1535-1540.
12. Engler, H., et al. (1999). Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodents. Urology 53: 1049-1053.
13. Pantazopoulos, D., Legakis, N., Antonakopoulos, G., Sofras, F., and Dimopoulos, C. (1987). The effect of pentosanpolysulphate and carbenoxolone on bacterial adherence to the injured urothelium. Br. J. Urol. 59: 423-426.
14. Zwiebel, J. A., Nagler, C., Smiley, J. K., and Cheson, B. D. (1998). Clinical trials referral resource: clinical trials of adenovirus-p53 gene therapy. Oncology (Huntington) 12: 1172, 1175.
15. Kuball, J., et al. (2002). Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation. J. Clin. Oncol. 20: 957-965.
16. Pagliaro, L. C., et al. (2003). Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy. J. Clin. Oncol. 21: 2247-2253.
17. Parsons, C. L., Stauffer, C., and Schmidt, J. D. (1980). Bladder-surface glycosaminoglycans: an efficient mechanism of environmental adaptation. Science 208: 605-607.
18. Yamashita, M., et al. (2002). Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer. Cancer Gene Ther. 9: 687-691.
19. Kirby, T. O., Curiel, D. T., and Alvarez, R. D. (2003). Gene therapy for ovarian cancer: progress and potential. Hematol. Oncol. Clin. North Am. 17: 1021-1050.
20. Shimada, H., Matsubara, H., and Ochiai, T. (2002). p53 gene therapy for esophageal cancer. J. Gastroenterol. 37: 87-91.
21. Rainov, N. G., and Ren, H. (2003). Gene therapy for human malignant brain tumors. Cancer J. 9: 180-188.
22. Pruchnic, R., Yokoyama, T., Lee, J. Y., Huard, J., and Chancellor, M. B. (2002). Muscle derived cell mediated ex vivo gene transfer to the lower urinary tract: comparison of viral vectors. Urol. Res. 30: 310-316.
23. Shayakhmetov, D. M., Papayannopoulou, T., Stamatoyannopoulos, G., and Lieber, A. (2000). Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J. Virol. 74: 2567-2583.
24. Marini, F. C., III, Cannon, J. P., Belmont, J. W., Shillitoe, E. J., and Lapeyre, J. N. (1995). In vivo marking of spontaneous or vaccine-induced fibrosarcomas in the domestic house cat, using an adenoviral vector containing a bifunctional fusion protein, GAL-TEK. Hum. Gene Ther. 6: 1215-1223.
25. Zolotukhin, S., et al. (1999). Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6: 973-985.
26. Bertran, J., et al. (1996). Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors. J. Virol. 70: 6759-6766.